Repligen | RGEN - Despesa De Juros Sobre A Dívida

Preço das Ações
131.21
Mudança Diária
4.12 3.24%
Mensal
11.58%
Anual
-0.33%
Q2 Previsão
116.82




Despesa De Juros Sobre A Dívida Alterar Data
Agilent USD 25M 2M 2025-12
Align Technology USD 2M 660K 2023-03
Bio Techne USD 2.18M 173K 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Bruker USD 20M 4.3M 2025-09
Charles River Laboratories USD 23.78M 1.63M 2025-12
Danaher USD 55M 12M 2025-12
Dentsply International USD 22M 1000K 2025-12
General Electric Aerospace USD 496M 271M 2025-12
Henry Schein USD 39M 1000K 2025-12
Illumina USD 25M 0 2025-09
IQVIA Holdings USD 193M 4M 2025-12
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 711M 59M 2025-12
Repligen USD 5.5M 81K 2025-12
Revvity USD 23.51M 742K 2025-12
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
Waters USD 8.62M 18.02M 2025-12
West Pharmaceutical Services USD 200K 100K 2025-09